Title: The "One Man" Who Slipped into the Viviant Trial: Why Medical Journals are Just Corrupt Priests Driven by Bribes

There is a drug for osteoporosis called Viviant (generic name: bazedoxifene). It is a medication specifically targeted at "postmenopausal women." Given its mechanism of action—targeting estrogen receptors to prevent bone loss—it goes without saying that its clinical trials should consist exclusively of female participants. But what would you think if, for some reason, "one male" managed to slip into that trial data? ■ Data Can Be "Cooked" In clinical trials, which demand the utmost strictness and rigor, the inclusion of a "male" who should absolutely be excluded is not a mere careless mistake. In an environment where such a "deviation from the rules"—mixing a man into research for a female-specific disease—is tolerated, the data population can be manipulated at will. Exclude inconvenient data, mix in convenient noise, and it becomes effortless for pharmaceutical companies to artificially engineer the "desired results" (efficacy) they want to see. But here lies the biggest question. Even if a pharmaceutical company submitted such "cosmetically enhanced data," how did it pass the rigorous peer review of a world-renowned, prestigious medical journal? Are we to believe that reviewers with genius-level intellects simply missed the "presence of this one man" (an obvious, glaring bug)? ■ The True Business Model of Prestigious Medical Journals They didn't miss it. They pretended not to notice. The reason lies in the massive vested interest held by medical journals: the alchemy known as "Reprints." Medical journals are not neutral, non-profit organizations. They are "publishers" pursuing profit. What happens when a journal approves a pharma company's paper for publication? The pharma company buys massive quantities of "reprints"—standalone copies of the exact pages proving their drug's efficacy—directly from the journal publisher. These orders range from tens of thousands to sometimes hundreds of thousands of copies. Why? Because they become the ultimate sales tool for pharma sales reps to distribute to doctors nationwide, boasting, "Here is the data published in that prestigious journal!" For the journal publisher, selling these reprints yields massive profits, ranging from millions to tens of millions of dollars. In other words, a perfect system of conflict of interest is in place: the more papers they approve that are favorable to pharmaceutical companies, the richer the journals become.
■ The "Indulgence" Business Disguised as Science As long as the pharma company provides the conclusion that "this drug is wonderful," the journal doesn't care if there's one man mixed into the trial data or if there are minor statistical contradictions. In exchange for enormous "reprint purchase fees" (which act as de facto bribes), the journal happily stamps the paper with the authoritative seal of being "scientifically correct." They are not neutral referees. They are exactly the same as the corrupt priests in medieval Europe who sold "indulgences," telling anyone who paid enough money, "Your sins are forgiven." When we hear the phrase "evidence published in a medical journal," we instinctively bow our heads in respect. But the reality is that it's nothing more than a bought-and-paid-for "endorsement from a cult leader." Only when we see through the statistical tricks (like ARR and RRR) and understand the "priests' business model" that approves those numbers, can we finally grasp the full picture of this colossal medical fraud.

Comments

Post a Comment

Popular posts from this blog

■ The "Hidden" Data: The Magic of Exclusion

Image
  Before we even reach the 90% efficacy claim, there is a more disturbing statistical maneuver hidden in the trial's methodology: Participant Exclusion. In the Pfizer Phase 3 trial, thousands of participants were excluded from the final "per-protocol" efficacy analysis after randomization. The stated reasons were "protocol deviations" or "missing data." However, when we look at who was excluded, a glaring anomaly emerges. Let us look at the approximate distribution of exclusions: Placebo Group Exclusions: ~500 individuals Vaccine Group Exclusions: ~3,500 individuals (Note: Use exact numbers from the specific FDA briefing document you are referencing if possible) Why were seven times as many people removed from the vaccine group after they received the shot but before the final counting? ■ The P-Value: Do the Math Yourself I won't just give you the answer. I want you to verify it yourself. Take these numbers: [Vaccine Excluded: 3500, Included:...
Read more

[Illustrated] The Giant Trap of "90% Vaccine Efficacy" – The Statistical Trick the Media Will Never Report

"90% vaccine efficacy!" the news loudly proclaims. When hearing this number, most people imagine a magic bullet where "if 100 people get the shot, 90 are saved." However, that is an ingenious, perfectly legal "statistical trick" orchestrated by the media and pharmaceutical companies. This time, let's unravel the actual data from Pfizer's Phase 3 clinical trial published in the NEJM, the world's most prestigious medical journal, and expose exactly how they "dress up" their numbers. ■ The Reality of the Data (Infections per 1,000 People) The trial divided about 40,000 people into two halves. If we convert the results to a more intuitive "per 1,000 people" metric, it looks like this: Placebo group (fake shot): Out of 1,000 people, about 7.5 were infected. Vaccine group (real shot): Out of 1,000 people, about 0.4 were infected. Now, this is where the magic begins. ■ How the Media Reports It: The Trap of "Relative Eva...
Read more

Episode 14: The Birth of the "Secret Treasury" — Why the Pension System was Actually Created in Japan

Image
 Welcome back to Bakuro-cho . Recently, a woman asked me: "Why was the pension system actually created?" My answer shocked her, but it is the cold, hard truth of history. In the mid-20th century, the bureaucrats of Japan’s Ministry of Health and Welfare (MHW) were looking at their rivals in the Ministry of Finance with envy. The Ministry of Finance controlled the nation’s taxes. The MHW wanted their own independent wealth. ■ The Great Bureaucratic Ambition The logic of the MHW Legions was simple and cynical: "We need a massive pool of money that we can manage and spend at our own discretion, without asking the Finance Ministry for permission." The solution? The Pension System. By forcing the entire working population to "save" for 40 years, the MHW created a massive, instant influx of cash. But they didn't lock this money in a vault for the future. They started spending the "contributions" immediately to build massive, unnecessary "we...
Read more